Log In
Print this Print this


Also known as: Col-101

  Manage Alerts
Collapse Summary General Information
Company Galderma S.A.
DescriptionOnce-daily modified-release formulation of doxycycline
Molecular Target Matrix metalloproteinases
Mechanism of ActionMatrix metalloproteinase inhibitor (MMPI)
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentMarketed
Standard IndicationRosacea
Indication DetailsTreat rosacea
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today